
The introduction of adjuvant approaches reduced the risk of disease recurrence in HER2-positive, early-stage breast cancer.

The introduction of adjuvant approaches reduced the risk of disease recurrence in HER2-positive, early-stage breast cancer.

Despite most wishing to die at home, nearly a third of patients with cancer die in the hospital. Goals-of-care discussions with nurses and other providers can help bring that number down.